• Anti – Inflammation Benefits recorded ca. 2000 B.C.

    Possibly the very earliest literature reference on Cannabis describes its use as an anti-inflammatory agent. The Chinese emperor Shen-nung (ca. 2000 B.C.), in a work called Pen-ts’ao Ching, noted many of the effects of Cannabis in humans. Among other properties, it was claimed that cannabis “undoes rheumatism”, suggesting possible anti-inflammatory effects*. The reports described in this review of the current […]

    Continue Reading
  • Appetite Loss

    The role of the endocannabinoid system in eating disorders: neurochemical and behavioural preclinical evidence. Scherma M, Fattore L, Castelli MP, Fratta W, Fadda P1. The endocannabinoid system has long been known as a modulator of several physiological functions, among which the homeostatic and hedonic aspects of eating. CB1 receptors are widely expressed in brain regions that control food intake, reward and energy balance. Animal and […]

    Continue Reading
  • Ancient History of CBD

    Medical Cannabis use has been recorded thousands of years ago in: Ancient Egypt The Ebers Papyrus (ca. 1550 BC) from Ancient Egypt has a prescription for medical marijuana applied directly for inflammation. The Ebers Papyrus (ca. 1550 BC) from Ancient Egypt describes medical cannabis.[9] Other ancient Egyptian papyri that mention medical cannabis are the Ramesseum III Papyrus (1700 BC), the Berlin Papyrus (1300 BC) and the Chester Beatty Medical Papyrus VI […]

    Continue Reading
  • Clinical Cannabinoid Medicine Curriculum

    EDUCATION:The Medical Cannabis Institute is offering a curriculum in Clinical Cannabinoid Medicine: Developed by the Society of Cannabis Clinicians (SCC), this is the first comprehensive, online CME-certified (Continuing Medical Education) curriculum in Clinical Cannabinoid Medicine designed to educate the practicing clinician on both the research and clinical practice aspects of the therapeutic use of cannabis. United Patients Group  […]

    Continue Reading
  • Anti-Psychotic Research

    According to several recent studies (on cannabidiol antipsychotic properties), Cannabidiol shows promise to alleviate certain psychotic symptoms and eventually may be considered as an alternative antipsychotic treatment. Though not as potent as many antipsychotic medications currently on the market, CBD seems to have fewer side effects, is more cost effective (when compared to other medications with [...] Continue Reading
  • CBD, THC and THCA are cannabinoids

    Alta California Botanicals™ are formulated by CBD Science, LLC – www.CBDscience.com – using scientific research and clinical data available in studies and US registered patents. Tinctures or CBMEs Alta California Botanicals™ are 100% organic tinctures formulated to provide fast acting and effective relief. The active ingredients combine CBD, THC, THCA and other cannabinoids in five […]

    Continue Reading